Zoekresultaten - 25 results
Healthcare-Associated Infections and Antimicrobial Use in Belgian Acute Care Hospitals: Results of the 2022 ECDC Point Prevalence Survey
prevalence was 8.5% (95% CI: 7.5-9.5%) when excluding HAI associated with long-term care facilities. Predominant infections included pneumonia and lower respiratory tract infections (32.8%, including COVID-19 ...
Prevalence of Healthcare-Associated Infections in Belgian Acute Care Hospitals in 2022: Results of ECDC Point Prevalence Survey
included pneumonia and lower respiratory tract infections (32.8%, including COVID-19 infections at 8.5%), surgical site infections (13.6%), urinary tract infections (18.5%), followed by bloodstream ...
First Belgian Report of Ertapenem Resistance in an ST11 Klebsiella Pneumoniae Strain Isolated from a Dog Carrying blaSCO-1 and blaDHA-1 Combined with Permeability Defects
Antibiotics, Volume 11, Issue 9 (2022) Keywords: antimicrobial resistance (AMR) carbapenem companion animal emerging risk hybrid sequencing Klebsiella pneumoniae OmpK37 Sepsis sequence type 11 Abstract: ...
First detection of a plasmid-encoded New-Delhi metallo-beta-lactamase-1 (NDM-1) producing Acinetobacter baumannii using whole genome sequencing, isolated in a clinical setting in Benin.
combatting increasing antibiotic resistance and development of new drugs. Since it was originally reported in Klebsiella pneumoniae in 2009, the quick spread of the bla gene encoding a New-Delhi ...
Decreasing and stabilising trends of antimicrobial consumption and resistance in and in segmented regression analysis, European Union/European Economic Area, 2001 to 2018.
Escherichia coli Escherichia coli Infections European Union Fluoroquinolones Humans Klebsiella Infections Klebsiella pneumoniae Microbial Sensitivity Tests Population Surveillance Abstract: Investments to ...
Surveillance of antimicrobial resistant bacteria in Belgian hospitals: Report 2016
Enterobacteriaceae, especially in Klebsiella pneumoniae (K. pneumoniae) in acute care hospitals. The mean resistance proportion of extended beta-lactamase producing (ESBL +) K. pneumoniae increased from 6.2% in 2005 to ...
European Antimicrobial Resistance Surveillance Network (EARS-Net Belgium)- Report 2017 (Data up to and including 2016)
fluoroquinolones, leading to countrywide resistance percentages in 2016 of 10.5% and 24.5%, respectively. An increasing trend could also be observed for antimicrobial resistance of Klebsiella pneumoniae to ...
OXA-48 Producing Klebsiella pneumoniae in a Household Contact of a Previously Infected Patient: Person-to-Person Transmission or Coincidental Community Acquisition?
Resistance, Multiple, Bacterial Electrophoresis, Gel, Pulsed-Field Family Characteristics Female Gene Expression Humans Klebsiella Infections Klebsiella pneumoniae Microbial Sensitivity Tests Multilocus ...
Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health.
being used as a last-resort drug to treat infections caused by multidrug-resistant (MDR) Pseudomonas aeruginosa, Acinetobacter baumannii and Enterobacteriaceae (e.g., Escherichia coli, Klebsiella ...
Surveillance of bloodstream infections in Belgian hospitals ('SEP')-Annual report 2014, Surveillance data 2000-2014
microorganisms involved in HA- BSI changed with an increase in the incidence of HA- BSI due to Gram-negative microorganisms (Escherichia coli, Klebsiella pneumoniae) and a decrease of HA- BSI due to ...